NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Actavis ( ACT) was upgraded at Leerink Swann to outperform from market perform. $155 price target. Company can exceed near-term earnings expectations, Leerink Swann said.

Air Products ( APD) was downgraded at Jefferies to hold. Valuation call, as the stock is up 22% since the beginning of May, Jefferies said. $104 price target.

Boston Scientific ( BSX) was upgraded to hold at TheStreet Ratings.

Cabot Oil & Gas ( COG - Get Report) was upgraded at Oppenheimer to outperform. Ratings change reflects strong top-line growth, Oppenheimer said. Unparalleled growth in shale-gas industry will generate high FCF, Oppenheimer also said. Price target $100.

Cash America ( CSH) was downgraded at Sterne Agee to underperform from neutral. Price target decreased to $36. There is weakness in U.S. pawn shop lending, and there is already scrutiny on small-bank ACH activity, Sterne Agee said.

Expedia ( EXPE - Get Report) was downgraded at Lazard Capital Markets to neutral from buy. Growth could decelerate in the coming quarters, Lazard Capital Markets said.

Flir Systems ( FLIR) was downgraded at J.P. Morgan to underweight from neutral. Price target is $29.50. Shares have reached the price target, downgrading on valuation, J.P. Morgan said.

Francesca's ( FRAN) was downgraded to neutral at Wedbush and given a $32 price target. Concerns about a short-term slowdown, Wedbush said. Lackluster mall traffic, contracting margins and a competitive back-to-school environment threaten FRAN's market share, Wedbush also said.

Hormel ( HRL) was upgraded at Credit Suisse to outperform from neutral. $46 price target. Company can outperform its peers in a difficult environment, Credit Suisse said.

KBR ( KBR) was downgraded at William Blair to market perform from outperform. $37 price target. Large projects are being delayed and the company has limited earnings upside potential, William Blair said.

Lazard ( LAZ) was upgraded to buy at TheStreet Ratings.

Lear ( LEA) was downgraded at UBS to neutral from buy. Valuation call, as the stock is up 44% year to date, UBS said. $70 price target.

Mettler-Toledo ( MTD) was upgraded at Cantor Fitzgerald to buy. Strong second-quarter beat and pending growth opportunities, said Cantor Fitzgerald. International expansion and margin growth potential drove the bull case and a new $252 price target, Cantor Fitzgerald said.

Noble Energy ( NBL - Get Report) was downgraded at Bank of America/Merrill Lynch to neutral from buy. $71 price target. Valuation call, as the stock has gained 30% since December, BofA/Merrill Lynch said.

Onyx Pharmaceuticals ( ONXX) was downgraded at Robert Baird to neutral from outperform. See limited upside potential to Amgen's bid for the company, Robert Baird said.

Quality Systems ( QSII) was upgraded at Sterne Agee to buy from neutral. Price target was increased to $28. Margins and system sales are going to drive EBITDA and EPS growth, Sterne Agee said.

Range Resources ( RRC) was upgraded at Oppenheimer to outperform and given a new $100 price target. Based on production growth, Oppenheimer said. RRC expects more long-term output growth, and the firm stands as an attractive acquisition target, Oppenheimer said.

Triumph ( TGI) estimates, price target were reduced at Credit Suisse. Shares are now seen reaching $88. Estimates were also cut, as the company is seeing growth headwinds, Credit Suisse said. Outperform rating.

Wesco ( WCC) was upgraded at Wunderlich to buy from hold. Stock is already pricing in negative factors, Wunderlich said.

Whole Foods ( WFM) was downgraded at Cantor Fitzgerald to hold from buy. See limited upside to estimates, Cantor Fitzgerald said. $54 price target.

Woodward ( WWD) was upgraded at Drexel Hamilton to buy from neutral. Price target is $48. The headwinds in the Wind/Renewables unit appears to be over, Drexel Hamilton said.

Stock Comments / EPS Changes

Abbvie ( ABBV) estimates, price target were raised at BMO Capital through 2014. Company's pipeline is advancing and guidance appears beatable, BMO Capital said. Market Perform rating and new $48 price target.

Activision ( ATVI) estimates, price target were boosted at Credit Suisse. Shares are now seen reaching $23. Estimates were also increased, following the Vivendi buyback. Outperform rating.

Celestica ( CLS) estimates, price target were raised at Citigroup. Shares are now seen reaching $9. Estimates were also increased, given higher realized telecom demand, Citi said. Sell rating.

Healthsouth ( HLS) estimates, price target were boosted at Lazard Capital Markets. Shares are now seen reaching $37. Estimates were also increased, given the company's new guidance. Buy rating.

Lear ( LEA) estimates, price target were increased at Citigroup. Estimates were increased through 2014. Company boosted its guidance, Citi said. Buy rating and new $79 price target.

Patterson-UTI ( PTEN) numbers were cut at UBS. Shares are now seen reaching $22. Estimates were also reduced, given difficult industry conditions, UBS said. Neutral rating.

Sprint ( S) estimates, price target were lowered at BMO Capital. Estimates were cut through 2014. Network Vision deployment appears to have fallen behind schedule, BMO Capital said. Outperform rating and new $7 price target.

Charles Schwab ( SCHW) numbers were raised at Credit Suisse. Shares are now seen reaching $19. Estimates were also increased, following an upbeat management update, Credit Suisse said. Neutral rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.